Weihong Zhao
ORCID: 0009-0000-8422-9723Also affiliated with Yancheng Institute of Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 2 papers. Top paper: “Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies”.
Jordi Rodon, Yan Liang, Xinhong Wu, Qun Li, Lihua Song +23 more
Xiuting Wang, Yaqin Li, Ying Bai, Qi Li, Shuling Wang +5 more